14-day RSI
46.06
+5.90+14.69%
27 November 2024
Summary:
Enlivex Therapeutics stock 14-day relative strength index is 46.06, with the most recent change of +5.90 (+14.69%) on 27 November 2024. According to this value, ENLV stock is neither oversold nor overboughtENLV RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV RSI Performance
PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
---|---|---|---|---|
todaytoday | +14.7% | +6.4% | -0.6% | -0.5% |
1 m1 month | -2.3% | -20.2% | -4.4% | -9.1% |
3 m3 months | +0.5% | -5.7% | +3.1% | -15.0% |
6 m6 months | +32.7% | -17.1% | -42.4% | -21.0% |
ytdytd | -30.0% | -57.0% | -22.1% | -21.9% |
1 y1 year | -24.3% | -38.6% | -12.9% | -28.8% |
5 y5 years | +1.8% | -86.4% | -89.3% | -88.6% |
ENLV RSI High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 47.93 | -3.9% | 14.62 | +215.1% |
3 m | 3 months | 71.51 | -35.6% | 14.62 | +215.1% |
6 m | 6 months | 71.51 | -35.6% | 14.62 | +215.1% |
1 y | 1 year | 80.17 | -42.5% | 14.62 | +215.1% |
3 y | 3 years | 87.04 | -47.1% | 13.27 | +247.1% |
5 y | 5 years | 92.34 | -50.1% | 13.27 | +247.1% |
alltime | all time | 92.34 | -50.1% | 0.00 | -100.0% |
Enlivex Therapeutics Stock RSI History
Date | Value |
---|---|
2024 | 46.06(-30.0%) |
2023 | 65.83(+52.9%) |
2022 | 43.06(+1.3%) |
2021 | 42.51(+16.7%) |
2020 | 36.43(-17.1%) |
Date | Value |
---|---|
2019 | 43.95(+43.7%) |
2018 | 30.59(-43.2%) |
2017 | 53.84(+55.1%) |
2016 | 34.71(-10.1%) |
2015 | 38.61(-24.4%) |
2014 | 51.07 |
FAQ
- What is Enlivex Therapeutics 14-day relative strength index?
- What is the all time high 14-day RSI for Enlivex Therapeutics?
What is Enlivex Therapeutics 14-day relative strength index?
The current 14-day RSI of ENLV is 46.06
What is the all time high 14-day RSI for Enlivex Therapeutics?
Enlivex Therapeutics all-time high 14-day relative strength index is 92.34